nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—hypertension—type 2 diabetes mellitus	0.769	1	CtDrD
Metolazone—Indapamide—KCNQ1—type 2 diabetes mellitus	0.00254	0.91	CrCbGaD
Metolazone—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00108	0.1	CbGeAlD
Metolazone—CA4—nerve—type 2 diabetes mellitus	0.00102	0.095	CbGeAlD
Metolazone—SLC12A3—nephron tubule—type 2 diabetes mellitus	0.000966	0.0902	CbGeAlD
Metolazone—CA7—kidney—type 2 diabetes mellitus	0.000867	0.0809	CbGeAlD
Metolazone—SLC12A3—kidney—type 2 diabetes mellitus	0.000849	0.0793	CbGeAlD
Metolazone—SLC12A3—cortex of kidney—type 2 diabetes mellitus	0.000827	0.0772	CbGeAlD
Metolazone—CA5A—liver—type 2 diabetes mellitus	0.000824	0.0769	CbGeAlD
Metolazone—CA12—kidney—type 2 diabetes mellitus	0.000563	0.0526	CbGeAlD
Metolazone—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000516	0.0482	CbGeAlD
Metolazone—CA5B—pancreas—type 2 diabetes mellitus	0.000502	0.0469	CbGeAlD
Metolazone—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000493	0.046	CbGeAlD
Metolazone—CA5B—adipose tissue—type 2 diabetes mellitus	0.000455	0.0425	CbGeAlD
Metolazone—CA4—nephron tubule—type 2 diabetes mellitus	0.000397	0.037	CbGeAlD
Metolazone—CA4—cardiovascular system—type 2 diabetes mellitus	0.000356	0.0333	CbGeAlD
Metolazone—CA4—kidney—type 2 diabetes mellitus	0.000349	0.0326	CbGeAlD
Metolazone—CA4—cortex of kidney—type 2 diabetes mellitus	0.00034	0.0317	CbGeAlD
Metolazone—CA4—adipose tissue—type 2 diabetes mellitus	0.000314	0.0293	CbGeAlD
Metolazone—Indapamide—CYP3A4—type 2 diabetes mellitus	0.000252	0.0903	CrCbGaD
Metolazone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000129	0.000734	CcSEcCtD
Metolazone—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000129	0.000732	CcSEcCtD
Metolazone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000731	CcSEcCtD
Metolazone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000129	0.00073	CcSEcCtD
Metolazone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000128	0.00073	CcSEcCtD
Metolazone—Hypertension—Metformin—type 2 diabetes mellitus	0.000128	0.000727	CcSEcCtD
Metolazone—Urticaria—Glyburide—type 2 diabetes mellitus	0.000128	0.000727	CcSEcCtD
Metolazone—Nervousness—Losartan—type 2 diabetes mellitus	0.000128	0.000726	CcSEcCtD
Metolazone—Back pain—Losartan—type 2 diabetes mellitus	0.000127	0.000724	CcSEcCtD
Metolazone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000127	0.000723	CcSEcCtD
Metolazone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000127	0.000723	CcSEcCtD
Metolazone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000127	0.00072	CcSEcCtD
Metolazone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000127	0.000719	CcSEcCtD
Metolazone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000126	0.000718	CcSEcCtD
Metolazone—Chest pain—Metformin—type 2 diabetes mellitus	0.000126	0.000717	CcSEcCtD
Metolazone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000126	0.000717	CcSEcCtD
Metolazone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000126	0.000714	CcSEcCtD
Metolazone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000126	0.000714	CcSEcCtD
Metolazone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000125	0.000713	CcSEcCtD
Metolazone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000711	CcSEcCtD
Metolazone—Discomfort—Metformin—type 2 diabetes mellitus	0.000125	0.000708	CcSEcCtD
Metolazone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000125	0.000708	CcSEcCtD
Metolazone—Nausea—Glipizide—type 2 diabetes mellitus	0.000124	0.000706	CcSEcCtD
Metolazone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000124	0.000705	CcSEcCtD
Metolazone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000124	0.000705	CcSEcCtD
Metolazone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000124	0.000703	CcSEcCtD
Metolazone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000124	0.000703	CcSEcCtD
Metolazone—Pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000703	CcSEcCtD
Metolazone—Rash—Glimepiride—type 2 diabetes mellitus	0.000123	0.0007	CcSEcCtD
Metolazone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000123	0.000699	CcSEcCtD
Metolazone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000123	0.000699	CcSEcCtD
Metolazone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000697	CcSEcCtD
Metolazone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000123	0.000697	CcSEcCtD
Metolazone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000123	0.000697	CcSEcCtD
Metolazone—Headache—Glimepiride—type 2 diabetes mellitus	0.000122	0.000695	CcSEcCtD
Metolazone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000122	0.000694	CcSEcCtD
Metolazone—Cough—Irbesartan—type 2 diabetes mellitus	0.000122	0.000694	CcSEcCtD
Metolazone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000693	CcSEcCtD
Metolazone—Anaemia—Losartan—type 2 diabetes mellitus	0.000122	0.000691	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000121	0.000688	CcSEcCtD
Metolazone—Agitation—Losartan—type 2 diabetes mellitus	0.000121	0.000687	CcSEcCtD
Metolazone—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000121	0.000687	CcSEcCtD
Metolazone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000121	0.000686	CcSEcCtD
Metolazone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000685	CcSEcCtD
Metolazone—Insomnia—Valsartan—type 2 diabetes mellitus	0.00012	0.000683	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00012	0.00068	CcSEcCtD
Metolazone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000119	0.000678	CcSEcCtD
Metolazone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000119	0.000677	CcSEcCtD
Metolazone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000119	0.000677	CcSEcCtD
Metolazone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000677	CcSEcCtD
Metolazone—Shock—Metformin—type 2 diabetes mellitus	0.000119	0.000676	CcSEcCtD
Metolazone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000119	0.000675	CcSEcCtD
Metolazone—Malaise—Losartan—type 2 diabetes mellitus	0.000119	0.000675	CcSEcCtD
Metolazone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000119	0.000674	CcSEcCtD
Metolazone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000119	0.000674	CcSEcCtD
Metolazone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000118	0.000673	CcSEcCtD
Metolazone—Vertigo—Losartan—type 2 diabetes mellitus	0.000118	0.000672	CcSEcCtD
Metolazone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000118	0.000672	CcSEcCtD
Metolazone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000118	0.000671	CcSEcCtD
Metolazone—Syncope—Losartan—type 2 diabetes mellitus	0.000118	0.000671	CcSEcCtD
Metolazone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000118	0.00067	CcSEcCtD
Metolazone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000118	0.00067	CcSEcCtD
Metolazone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000118	0.000669	CcSEcCtD
Metolazone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000117	0.000664	CcSEcCtD
Metolazone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000116	0.000662	CcSEcCtD
Metolazone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000116	0.000662	CcSEcCtD
Metolazone—Palpitations—Losartan—type 2 diabetes mellitus	0.000116	0.000661	CcSEcCtD
Metolazone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000116	0.000659	CcSEcCtD
Metolazone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000116	0.000657	CcSEcCtD
Metolazone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000657	CcSEcCtD
Metolazone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000116	0.000657	CcSEcCtD
Metolazone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Metolazone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000115	0.000656	CcSEcCtD
Metolazone—Anorexia—Metformin—type 2 diabetes mellitus	0.000115	0.000655	CcSEcCtD
Metolazone—Cough—Losartan—type 2 diabetes mellitus	0.000115	0.000653	CcSEcCtD
Metolazone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000115	0.000653	CcSEcCtD
Metolazone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000114	0.000651	CcSEcCtD
Metolazone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000114	0.000649	CcSEcCtD
Metolazone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000114	0.000648	CcSEcCtD
Metolazone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000114	0.000647	CcSEcCtD
Metolazone—Constipation—Valsartan—type 2 diabetes mellitus	0.000114	0.000645	CcSEcCtD
Metolazone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000113	0.000643	CcSEcCtD
Metolazone—Shock—Irbesartan—type 2 diabetes mellitus	0.000112	0.000638	CcSEcCtD
Metolazone—Pain—Orlistat—type 2 diabetes mellitus	0.000112	0.000638	CcSEcCtD
Metolazone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000112	0.000637	CcSEcCtD
Metolazone—Chest pain—Losartan—type 2 diabetes mellitus	0.000112	0.000637	CcSEcCtD
Metolazone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000636	CcSEcCtD
Metolazone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000635	CcSEcCtD
Metolazone—Anxiety—Losartan—type 2 diabetes mellitus	0.000112	0.000635	CcSEcCtD
Metolazone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000631	CcSEcCtD
Metolazone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000111	0.00063	CcSEcCtD
Metolazone—Tension—Ramipril—type 2 diabetes mellitus	0.000111	0.000629	CcSEcCtD
Metolazone—Discomfort—Losartan—type 2 diabetes mellitus	0.000111	0.000629	CcSEcCtD
Metolazone—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000111	0.000628	CcSEcCtD
Metolazone—Headache—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000627	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00011	0.000626	CcSEcCtD
Metolazone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00011	0.000626	CcSEcCtD
Metolazone—Nervousness—Ramipril—type 2 diabetes mellitus	0.00011	0.000623	CcSEcCtD
Metolazone—Dry mouth—Losartan—type 2 diabetes mellitus	0.00011	0.000623	CcSEcCtD
Metolazone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000618	CcSEcCtD
Metolazone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000109	0.000617	CcSEcCtD
Metolazone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000109	0.000617	CcSEcCtD
Metolazone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000108	0.000617	CcSEcCtD
Metolazone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000108	0.000615	CcSEcCtD
Metolazone—Somnolence—Metformin—type 2 diabetes mellitus	0.000108	0.000611	CcSEcCtD
Metolazone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000107	0.00061	CcSEcCtD
Metolazone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000106	0.000605	CcSEcCtD
Metolazone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000106	0.000605	CcSEcCtD
Metolazone—Shock—Losartan—type 2 diabetes mellitus	0.000106	0.000601	CcSEcCtD
Metolazone—Urticaria—Valsartan—type 2 diabetes mellitus	0.000105	0.0006	CcSEcCtD
Metolazone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000105	0.000598	CcSEcCtD
Metolazone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000105	0.000598	CcSEcCtD
Metolazone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000105	0.000597	CcSEcCtD
Metolazone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000105	0.000595	CcSEcCtD
Metolazone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000595	CcSEcCtD
Metolazone—Fatigue—Metformin—type 2 diabetes mellitus	0.000104	0.000593	CcSEcCtD
Metolazone—Urticaria—Orlistat—type 2 diabetes mellitus	0.000104	0.000593	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000104	0.000591	CcSEcCtD
Metolazone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000104	0.00059	CcSEcCtD
Metolazone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000104	0.000589	CcSEcCtD
Metolazone—Agitation—Ramipril—type 2 diabetes mellitus	0.000104	0.000589	CcSEcCtD
Metolazone—Constipation—Metformin—type 2 diabetes mellitus	0.000103	0.000588	CcSEcCtD
Metolazone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000582	CcSEcCtD
Metolazone—Anorexia—Losartan—type 2 diabetes mellitus	0.000102	0.000582	CcSEcCtD
Metolazone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000102	0.000582	CcSEcCtD
Metolazone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000102	0.000581	CcSEcCtD
Metolazone—Malaise—Ramipril—type 2 diabetes mellitus	0.000102	0.000578	CcSEcCtD
Metolazone—Rash—Glyburide—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Metolazone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000101	0.000577	CcSEcCtD
Metolazone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000101	0.000576	CcSEcCtD
Metolazone—Vertigo—Ramipril—type 2 diabetes mellitus	0.000101	0.000576	CcSEcCtD
Metolazone—Syncope—Ramipril—type 2 diabetes mellitus	0.000101	0.000575	CcSEcCtD
Metolazone—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000101	0.000574	CcSEcCtD
Metolazone—Headache—Glyburide—type 2 diabetes mellitus	0.000101	0.000573	CcSEcCtD
Metolazone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.0001	0.000571	CcSEcCtD
Metolazone—Palpitations—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000567	CcSEcCtD
Metolazone—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.97e-05	0.000566	CcSEcCtD
Metolazone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.92e-05	0.000564	CcSEcCtD
Metolazone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	9.92e-05	0.000564	CcSEcCtD
Metolazone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.89e-05	0.000562	CcSEcCtD
Metolazone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.89e-05	0.000562	CcSEcCtD
Metolazone—Cough—Ramipril—type 2 diabetes mellitus	9.85e-05	0.00056	CcSEcCtD
Metolazone—Fatigue—Irbesartan—type 2 diabetes mellitus	9.84e-05	0.000559	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.79e-05	0.000556	CcSEcCtD
Metolazone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000556	CcSEcCtD
Metolazone—Pain—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.000555	CcSEcCtD
Metolazone—Constipation—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.000555	CcSEcCtD
Metolazone—Insomnia—Losartan—type 2 diabetes mellitus	9.71e-05	0.000552	CcSEcCtD
Metolazone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.67e-05	0.00055	CcSEcCtD
Metolazone—Paraesthesia—Losartan—type 2 diabetes mellitus	9.64e-05	0.000548	CcSEcCtD
Metolazone—Urticaria—Metformin—type 2 diabetes mellitus	9.61e-05	0.000546	CcSEcCtD
Metolazone—Arthralgia—Ramipril—type 2 diabetes mellitus	9.61e-05	0.000546	CcSEcCtD
Metolazone—Chest pain—Ramipril—type 2 diabetes mellitus	9.61e-05	0.000546	CcSEcCtD
Metolazone—Anxiety—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000544	CcSEcCtD
Metolazone—Nausea—Glyburide—type 2 diabetes mellitus	9.56e-05	0.000543	CcSEcCtD
Metolazone—Abdominal pain—Metformin—type 2 diabetes mellitus	9.56e-05	0.000543	CcSEcCtD
Metolazone—Dizziness—Gliclazide—type 2 diabetes mellitus	9.56e-05	0.000543	CcSEcCtD
Metolazone—Somnolence—Losartan—type 2 diabetes mellitus	9.55e-05	0.000543	CcSEcCtD
Metolazone—Asthenia—Valsartan—type 2 diabetes mellitus	9.53e-05	0.000542	CcSEcCtD
Metolazone—Discomfort—Ramipril—type 2 diabetes mellitus	9.49e-05	0.00054	CcSEcCtD
Metolazone—Dyspepsia—Losartan—type 2 diabetes mellitus	9.45e-05	0.000537	CcSEcCtD
Metolazone—Asthenia—Orlistat—type 2 diabetes mellitus	9.41e-05	0.000535	CcSEcCtD
Metolazone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.4e-05	0.000535	CcSEcCtD
Metolazone—Pruritus—Valsartan—type 2 diabetes mellitus	9.4e-05	0.000534	CcSEcCtD
Metolazone—Dry mouth—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000534	CcSEcCtD
Metolazone—Decreased appetite—Losartan—type 2 diabetes mellitus	9.34e-05	0.000531	CcSEcCtD
Metolazone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.33e-05	0.00053	CcSEcCtD
Metolazone—Pruritus—Orlistat—type 2 diabetes mellitus	9.28e-05	0.000528	CcSEcCtD
Metolazone—Fatigue—Losartan—type 2 diabetes mellitus	9.26e-05	0.000526	CcSEcCtD
Metolazone—Vomiting—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000522	CcSEcCtD
Metolazone—Pain—Losartan—type 2 diabetes mellitus	9.18e-05	0.000522	CcSEcCtD
Metolazone—Constipation—Losartan—type 2 diabetes mellitus	9.18e-05	0.000522	CcSEcCtD
Metolazone—Rash—Gliclazide—type 2 diabetes mellitus	9.11e-05	0.000518	CcSEcCtD
Metolazone—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.11e-05	0.000518	CcSEcCtD
Metolazone—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000516	CcSEcCtD
Metolazone—Urticaria—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000515	CcSEcCtD
Metolazone—Shock—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000515	CcSEcCtD
Metolazone—Headache—Gliclazide—type 2 diabetes mellitus	9.06e-05	0.000515	CcSEcCtD
Metolazone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000513	CcSEcCtD
Metolazone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000513	CcSEcCtD
Metolazone—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.98e-05	0.00051	CcSEcCtD
Metolazone—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.85e-05	0.000503	CcSEcCtD
Metolazone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.78e-05	0.000499	CcSEcCtD
Metolazone—Dizziness—Valsartan—type 2 diabetes mellitus	8.78e-05	0.000499	CcSEcCtD
Metolazone—Anorexia—Ramipril—type 2 diabetes mellitus	8.78e-05	0.000499	CcSEcCtD
Metolazone—Dizziness—Orlistat—type 2 diabetes mellitus	8.68e-05	0.000493	CcSEcCtD
Metolazone—Asthenia—Metformin—type 2 diabetes mellitus	8.68e-05	0.000493	CcSEcCtD
Metolazone—Nausea—Gliclazide—type 2 diabetes mellitus	8.59e-05	0.000488	CcSEcCtD
Metolazone—Pruritus—Metformin—type 2 diabetes mellitus	8.56e-05	0.000486	CcSEcCtD
Metolazone—Urticaria—Losartan—type 2 diabetes mellitus	8.53e-05	0.000485	CcSEcCtD
Metolazone—Abdominal pain—Losartan—type 2 diabetes mellitus	8.49e-05	0.000483	CcSEcCtD
Metolazone—Vomiting—Valsartan—type 2 diabetes mellitus	8.44e-05	0.00048	CcSEcCtD
Metolazone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000478	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.39e-05	0.000477	CcSEcCtD
Metolazone—Rash—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000476	CcSEcCtD
Metolazone—Dermatitis—Valsartan—type 2 diabetes mellitus	8.37e-05	0.000475	CcSEcCtD
Metolazone—Vomiting—Orlistat—type 2 diabetes mellitus	8.34e-05	0.000474	CcSEcCtD
Metolazone—Insomnia—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000473	CcSEcCtD
Metolazone—Headache—Valsartan—type 2 diabetes mellitus	8.32e-05	0.000473	CcSEcCtD
Metolazone—Diarrhoea—Metformin—type 2 diabetes mellitus	8.27e-05	0.00047	CcSEcCtD
Metolazone—Rash—Orlistat—type 2 diabetes mellitus	8.27e-05	0.00047	CcSEcCtD
Metolazone—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.27e-05	0.00047	CcSEcCtD
Metolazone—Dermatitis—Orlistat—type 2 diabetes mellitus	8.27e-05	0.00047	CcSEcCtD
Metolazone—Headache—Orlistat—type 2 diabetes mellitus	8.22e-05	0.000467	CcSEcCtD
Metolazone—Asthenia—Irbesartan—type 2 diabetes mellitus	8.19e-05	0.000465	CcSEcCtD
Metolazone—Somnolence—Ramipril—type 2 diabetes mellitus	8.19e-05	0.000465	CcSEcCtD
Metolazone—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.11e-05	0.000461	CcSEcCtD
Metolazone—Pruritus—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000459	CcSEcCtD
Metolazone—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.01e-05	0.000455	CcSEcCtD
Metolazone—Dizziness—Metformin—type 2 diabetes mellitus	8e-05	0.000455	CcSEcCtD
Metolazone—Fatigue—Ramipril—type 2 diabetes mellitus	7.94e-05	0.000451	CcSEcCtD
Metolazone—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.91e-05	0.00045	CcSEcCtD
Metolazone—Nausea—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000448	CcSEcCtD
Metolazone—Constipation—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000448	CcSEcCtD
Metolazone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000444	CcSEcCtD
Metolazone—Nausea—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000443	CcSEcCtD
Metolazone—Asthenia—Losartan—type 2 diabetes mellitus	7.71e-05	0.000438	CcSEcCtD
Metolazone—Vomiting—Metformin—type 2 diabetes mellitus	7.69e-05	0.000437	CcSEcCtD
Metolazone—Rash—Metformin—type 2 diabetes mellitus	7.63e-05	0.000433	CcSEcCtD
Metolazone—Dermatitis—Metformin—type 2 diabetes mellitus	7.62e-05	0.000433	CcSEcCtD
Metolazone—Pruritus—Losartan—type 2 diabetes mellitus	7.6e-05	0.000432	CcSEcCtD
Metolazone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000431	CcSEcCtD
Metolazone—Headache—Metformin—type 2 diabetes mellitus	7.58e-05	0.000431	CcSEcCtD
Metolazone—Dizziness—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000429	CcSEcCtD
Metolazone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.53e-05	0.000428	CcSEcCtD
Metolazone—Diarrhoea—Losartan—type 2 diabetes mellitus	7.35e-05	0.000418	CcSEcCtD
Metolazone—Urticaria—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000416	CcSEcCtD
Metolazone—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000414	CcSEcCtD
Metolazone—Vomiting—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000412	CcSEcCtD
Metolazone—Rash—Irbesartan—type 2 diabetes mellitus	7.2e-05	0.000409	CcSEcCtD
Metolazone—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.19e-05	0.000409	CcSEcCtD
Metolazone—Nausea—Metformin—type 2 diabetes mellitus	7.18e-05	0.000408	CcSEcCtD
Metolazone—Headache—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000406	CcSEcCtD
Metolazone—Dizziness—Losartan—type 2 diabetes mellitus	7.1e-05	0.000404	CcSEcCtD
Metolazone—Vomiting—Losartan—type 2 diabetes mellitus	6.83e-05	0.000388	CcSEcCtD
Metolazone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000386	CcSEcCtD
Metolazone—Nausea—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000385	CcSEcCtD
Metolazone—Rash—Losartan—type 2 diabetes mellitus	6.77e-05	0.000385	CcSEcCtD
Metolazone—Dermatitis—Losartan—type 2 diabetes mellitus	6.77e-05	0.000385	CcSEcCtD
Metolazone—Headache—Losartan—type 2 diabetes mellitus	6.73e-05	0.000382	CcSEcCtD
Metolazone—Asthenia—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000376	CcSEcCtD
Metolazone—Pruritus—Ramipril—type 2 diabetes mellitus	6.52e-05	0.00037	CcSEcCtD
Metolazone—Nausea—Losartan—type 2 diabetes mellitus	6.38e-05	0.000363	CcSEcCtD
Metolazone—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000358	CcSEcCtD
Metolazone—Dizziness—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000346	CcSEcCtD
Metolazone—Vomiting—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000333	CcSEcCtD
Metolazone—Rash—Ramipril—type 2 diabetes mellitus	5.81e-05	0.00033	CcSEcCtD
Metolazone—Dermatitis—Ramipril—type 2 diabetes mellitus	5.8e-05	0.00033	CcSEcCtD
Metolazone—Headache—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000328	CcSEcCtD
Metolazone—Nausea—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000311	CcSEcCtD
Metolazone—CA9—Metabolism—NCOA6—type 2 diabetes mellitus	3.99e-05	0.000961	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SNAP25—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA7—Metabolism—SNAP25—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA7—Metabolism—PSMD6—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PSMD6—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SREBF1—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA7—Metabolism—SREBF1—type 2 diabetes mellitus	3.98e-05	0.000959	CbGpPWpGaD
Metolazone—CA12—Metabolism—CETP—type 2 diabetes mellitus	3.97e-05	0.000956	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—RELA—type 2 diabetes mellitus	3.97e-05	0.000956	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALDOB—type 2 diabetes mellitus	3.96e-05	0.000953	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD11B1—type 2 diabetes mellitus	3.93e-05	0.000945	CbGpPWpGaD
Metolazone—CA9—Metabolism—UCP3—type 2 diabetes mellitus	3.93e-05	0.000945	CbGpPWpGaD
Metolazone—CA9—Metabolism—UCP2—type 2 diabetes mellitus	3.93e-05	0.000945	CbGpPWpGaD
Metolazone—CA7—Metabolism—CTGF—type 2 diabetes mellitus	3.91e-05	0.000941	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CTGF—type 2 diabetes mellitus	3.91e-05	0.000941	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2E1—type 2 diabetes mellitus	3.9e-05	0.000939	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMGCR—type 2 diabetes mellitus	3.88e-05	0.000933	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMGCR—type 2 diabetes mellitus	3.88e-05	0.000933	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC2A1—type 2 diabetes mellitus	3.86e-05	0.000929	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1A2—type 2 diabetes mellitus	3.86e-05	0.000929	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-05	0.000913	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-05	0.000913	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP3A4—type 2 diabetes mellitus	3.76e-05	0.000906	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GCG—type 2 diabetes mellitus	3.7e-05	0.000891	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SLC2A4—type 2 diabetes mellitus	3.7e-05	0.000891	CbGpPWpGaD
Metolazone—CA12—Metabolism—PSMD6—type 2 diabetes mellitus	3.69e-05	0.000888	CbGpPWpGaD
Metolazone—CA12—Metabolism—SNAP25—type 2 diabetes mellitus	3.69e-05	0.000888	CbGpPWpGaD
Metolazone—CA12—Metabolism—SREBF1—type 2 diabetes mellitus	3.69e-05	0.000888	CbGpPWpGaD
Metolazone—CA9—Metabolism—PCK1—type 2 diabetes mellitus	3.69e-05	0.000888	CbGpPWpGaD
Metolazone—CA4—Metabolism—GLP1R—type 2 diabetes mellitus	3.68e-05	0.000886	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-05	0.000877	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-05	0.000877	CbGpPWpGaD
Metolazone—CA12—Metabolism—CTGF—type 2 diabetes mellitus	3.62e-05	0.000872	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1A2—type 2 diabetes mellitus	3.6e-05	0.000867	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-05	0.000867	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1A2—type 2 diabetes mellitus	3.6e-05	0.000867	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-05	0.000867	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMGCR—type 2 diabetes mellitus	3.59e-05	0.000864	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-05	0.000846	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-05	0.000846	CbGpPWpGaD
Metolazone—CA12—Metabolism—ADRA2A—type 2 diabetes mellitus	3.51e-05	0.000846	CbGpPWpGaD
Metolazone—CA9—Metabolism—HK1—type 2 diabetes mellitus	3.46e-05	0.000832	CbGpPWpGaD
Metolazone—CA7—Metabolism—GCG—type 2 diabetes mellitus	3.45e-05	0.000831	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GCG—type 2 diabetes mellitus	3.45e-05	0.000831	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-05	0.000831	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-05	0.000831	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.44e-05	0.000827	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2E1—type 2 diabetes mellitus	3.38e-05	0.000813	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTR—type 2 diabetes mellitus	3.37e-05	0.000811	CbGpPWpGaD
Metolazone—CA4—Metabolism—CPT1A—type 2 diabetes mellitus	3.37e-05	0.000811	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—NFKB1—type 2 diabetes mellitus	3.35e-05	0.000806	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD3B2—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCKR—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA9—Metabolism—KCNJ11—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC2A1—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPA—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1A2—type 2 diabetes mellitus	3.34e-05	0.000803	CbGpPWpGaD
Metolazone—CA4—Metabolism—NAMPT—type 2 diabetes mellitus	3.3e-05	0.000795	CbGpPWpGaD
Metolazone—CA4—Metabolism—GCK—type 2 diabetes mellitus	3.28e-05	0.00079	CbGpPWpGaD
Metolazone—CA4—Metabolism—LIPC—type 2 diabetes mellitus	3.28e-05	0.00079	CbGpPWpGaD
Metolazone—CA4—Metabolism—HBA1—type 2 diabetes mellitus	3.28e-05	0.00079	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.26e-05	0.000785	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP3A4—type 2 diabetes mellitus	3.26e-05	0.000784	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.25e-05	0.000783	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.2e-05	0.000771	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC2A4—type 2 diabetes mellitus	3.2e-05	0.00077	CbGpPWpGaD
Metolazone—CA12—Metabolism—GCG—type 2 diabetes mellitus	3.2e-05	0.00077	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDOB—type 2 diabetes mellitus	3.2e-05	0.00077	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GNB3—type 2 diabetes mellitus	3.19e-05	0.000768	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.19e-05	0.000768	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMOX1—type 2 diabetes mellitus	3.17e-05	0.000764	CbGpPWpGaD
Metolazone—CA4—Metabolism—CETP—type 2 diabetes mellitus	3.17e-05	0.000762	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAT—type 2 diabetes mellitus	3.13e-05	0.000754	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOB—type 2 diabetes mellitus	3.04e-05	0.000732	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—type 2 diabetes mellitus	3.04e-05	0.000731	CbGpPWpGaD
Metolazone—CA7—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-05	0.000717	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-05	0.000717	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-05	0.000717	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-05	0.000717	CbGpPWpGaD
Metolazone—CA9—Metabolism—GLP1R—type 2 diabetes mellitus	2.98e-05	0.000716	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-05	0.000713	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-05	0.000713	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—type 2 diabetes mellitus	2.96e-05	0.000712	CbGpPWpGaD
Metolazone—CA4—Metabolism—PSMD6—type 2 diabetes mellitus	2.94e-05	0.000708	CbGpPWpGaD
Metolazone—CA4—Metabolism—SREBF1—type 2 diabetes mellitus	2.94e-05	0.000708	CbGpPWpGaD
Metolazone—CA4—Metabolism—SNAP25—type 2 diabetes mellitus	2.94e-05	0.000708	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAT—type 2 diabetes mellitus	2.92e-05	0.000704	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAT—type 2 diabetes mellitus	2.92e-05	0.000704	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPL—type 2 diabetes mellitus	2.9e-05	0.000699	CbGpPWpGaD
Metolazone—CA4—Metabolism—CTGF—type 2 diabetes mellitus	2.89e-05	0.000695	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMGCR—type 2 diabetes mellitus	2.86e-05	0.000689	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ADCY5—type 2 diabetes mellitus	2.84e-05	0.000684	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOB—type 2 diabetes mellitus	2.84e-05	0.000683	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOB—type 2 diabetes mellitus	2.84e-05	0.000683	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—type 2 diabetes mellitus	2.83e-05	0.000682	CbGpPWpGaD
Metolazone—CA4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.8e-05	0.000674	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.78e-05	0.000669	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-05	0.000665	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-05	0.000665	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CD36—type 2 diabetes mellitus	2.76e-05	0.000664	CbGpPWpGaD
Metolazone—CA12—Metabolism—GNB3—type 2 diabetes mellitus	2.76e-05	0.000664	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.76e-05	0.000664	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMOX1—type 2 diabetes mellitus	2.75e-05	0.000661	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPP2CA—type 2 diabetes mellitus	2.72e-05	0.000656	CbGpPWpGaD
Metolazone—CA9—Metabolism—CPT1A—type 2 diabetes mellitus	2.72e-05	0.000655	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTR—type 2 diabetes mellitus	2.72e-05	0.000655	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPL—type 2 diabetes mellitus	2.71e-05	0.000652	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPL—type 2 diabetes mellitus	2.71e-05	0.000652	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAT—type 2 diabetes mellitus	2.71e-05	0.000652	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.69e-05	0.000648	CbGpPWpGaD
Metolazone—CA9—Metabolism—NAMPT—type 2 diabetes mellitus	2.67e-05	0.000642	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.66e-05	0.000641	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.66e-05	0.000641	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-05	0.000639	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-05	0.000639	CbGpPWpGaD
Metolazone—CA9—Metabolism—HBA1—type 2 diabetes mellitus	2.65e-05	0.000638	CbGpPWpGaD
Metolazone—CA9—Metabolism—LIPC—type 2 diabetes mellitus	2.65e-05	0.000638	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCK—type 2 diabetes mellitus	2.65e-05	0.000638	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-05	0.000637	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-05	0.000637	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.64e-05	0.000634	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOB—type 2 diabetes mellitus	2.63e-05	0.000633	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—type 2 diabetes mellitus	2.61e-05	0.000629	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP3A4—type 2 diabetes mellitus	2.6e-05	0.000625	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.59e-05	0.000623	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CD36—type 2 diabetes mellitus	2.58e-05	0.00062	CbGpPWpGaD
Metolazone—CA7—Metabolism—CD36—type 2 diabetes mellitus	2.58e-05	0.00062	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARA—type 2 diabetes mellitus	2.56e-05	0.000617	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—type 2 diabetes mellitus	2.56e-05	0.000616	CbGpPWpGaD
Metolazone—CA9—Metabolism—CETP—type 2 diabetes mellitus	2.56e-05	0.000616	CbGpPWpGaD
Metolazone—CA4—Metabolism—GCG—type 2 diabetes mellitus	2.55e-05	0.000614	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.55e-05	0.000614	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-05	0.000612	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-05	0.000612	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPL—type 2 diabetes mellitus	2.51e-05	0.000604	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AGT—type 2 diabetes mellitus	2.48e-05	0.000598	CbGpPWpGaD
Metolazone—CA12—Metabolism—ADCY5—type 2 diabetes mellitus	2.46e-05	0.000592	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—type 2 diabetes mellitus	2.45e-05	0.00059	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CALM1—type 2 diabetes mellitus	2.44e-05	0.000588	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-05	0.000587	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-05	0.000587	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOE—type 2 diabetes mellitus	2.43e-05	0.000586	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOA1—type 2 diabetes mellitus	2.41e-05	0.000579	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-05	0.000576	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-05	0.000576	CbGpPWpGaD
Metolazone—CA12—Metabolism—CD36—type 2 diabetes mellitus	2.39e-05	0.000574	CbGpPWpGaD
Metolazone—CA9—Metabolism—PSMD6—type 2 diabetes mellitus	2.38e-05	0.000572	CbGpPWpGaD
Metolazone—CA9—Metabolism—SREBF1—type 2 diabetes mellitus	2.38e-05	0.000572	CbGpPWpGaD
Metolazone—CA9—Metabolism—SNAP25—type 2 diabetes mellitus	2.38e-05	0.000572	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPP2CA—type 2 diabetes mellitus	2.36e-05	0.000567	CbGpPWpGaD
Metolazone—CA9—Metabolism—CTGF—type 2 diabetes mellitus	2.33e-05	0.000562	CbGpPWpGaD
Metolazone—CA7—Metabolism—AGT—type 2 diabetes mellitus	2.32e-05	0.000558	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AGT—type 2 diabetes mellitus	2.32e-05	0.000558	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMGCR—type 2 diabetes mellitus	2.31e-05	0.000557	CbGpPWpGaD
Metolazone—CA7—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-05	0.000549	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-05	0.000549	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOE—type 2 diabetes mellitus	2.27e-05	0.000547	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOE—type 2 diabetes mellitus	2.27e-05	0.000547	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.26e-05	0.000545	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—type 2 diabetes mellitus	2.26e-05	0.000544	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-05	0.000541	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-05	0.000541	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARA—type 2 diabetes mellitus	2.22e-05	0.000534	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.2e-05	0.000529	CbGpPWpGaD
Metolazone—CA4—Metabolism—GNB3—type 2 diabetes mellitus	2.2e-05	0.000529	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—type 2 diabetes mellitus	2.19e-05	0.000527	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.18e-05	0.000524	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAT—type 2 diabetes mellitus	2.16e-05	0.00052	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.15e-05	0.000518	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.15e-05	0.000518	CbGpPWpGaD
Metolazone—CA12—Metabolism—AGT—type 2 diabetes mellitus	2.15e-05	0.000517	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARG—type 2 diabetes mellitus	2.12e-05	0.00051	CbGpPWpGaD
Metolazone—CA12—Metabolism—CALM1—type 2 diabetes mellitus	2.11e-05	0.000508	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOE—type 2 diabetes mellitus	2.1e-05	0.000507	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—type 2 diabetes mellitus	2.1e-05	0.000506	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.1e-05	0.000505	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOB—type 2 diabetes mellitus	2.1e-05	0.000505	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA1—type 2 diabetes mellitus	2.08e-05	0.000501	CbGpPWpGaD
Metolazone—CA5A—Metabolism—INS—type 2 diabetes mellitus	2.08e-05	0.0005	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCG—type 2 diabetes mellitus	2.06e-05	0.000496	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.06e-05	0.000496	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	2.04e-05	0.000491	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPL—type 2 diabetes mellitus	2e-05	0.000482	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-05	0.000476	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-05	0.000476	CbGpPWpGaD
Metolazone—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	1.96e-05	0.000472	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—type 2 diabetes mellitus	1.95e-05	0.00047	CbGpPWpGaD
Metolazone—CA7—Metabolism—INS—type 2 diabetes mellitus	1.94e-05	0.000467	CbGpPWpGaD
Metolazone—CA5B—Metabolism—INS—type 2 diabetes mellitus	1.94e-05	0.000467	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—type 2 diabetes mellitus	1.91e-05	0.000459	CbGpPWpGaD
Metolazone—CA4—Metabolism—CD36—type 2 diabetes mellitus	1.9e-05	0.000458	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.88e-05	0.000452	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-05	0.000441	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—type 2 diabetes mellitus	1.82e-05	0.000439	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.82e-05	0.000439	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	1.8e-05	0.000434	CbGpPWpGaD
Metolazone—CA12—Metabolism—INS—type 2 diabetes mellitus	1.8e-05	0.000433	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—type 2 diabetes mellitus	1.78e-05	0.000428	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—type 2 diabetes mellitus	1.78e-05	0.000428	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.78e-05	0.000428	CbGpPWpGaD
Metolazone—CA9—Metabolism—GNB3—type 2 diabetes mellitus	1.78e-05	0.000428	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	1.77e-05	0.000426	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARA—type 2 diabetes mellitus	1.77e-05	0.000426	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAT—type 2 diabetes mellitus	1.75e-05	0.00042	CbGpPWpGaD
Metolazone—CA4—Metabolism—AGT—type 2 diabetes mellitus	1.71e-05	0.000412	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.00041	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-05	0.00041	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-05	0.00041	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.00041	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOB—type 2 diabetes mellitus	1.69e-05	0.000408	CbGpPWpGaD
Metolazone—CA4—Metabolism—CALM1—type 2 diabetes mellitus	1.68e-05	0.000405	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOE—type 2 diabetes mellitus	1.68e-05	0.000404	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	1.67e-05	0.000401	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA1—type 2 diabetes mellitus	1.66e-05	0.000399	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—type 2 diabetes mellitus	1.65e-05	0.000397	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	1.65e-05	0.000397	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPL—type 2 diabetes mellitus	1.62e-05	0.000389	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	1.58e-05	0.000381	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—type 2 diabetes mellitus	1.58e-05	0.00038	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	1.58e-05	0.00038	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—type 2 diabetes mellitus	1.58e-05	0.00038	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-05	0.000375	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-05	0.000375	CbGpPWpGaD
Metolazone—CA9—Metabolism—CD36—type 2 diabetes mellitus	1.54e-05	0.00037	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.52e-05	0.000365	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARG—type 2 diabetes mellitus	1.46e-05	0.000352	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	1.46e-05	0.000351	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	1.44e-05	0.000347	CbGpPWpGaD
Metolazone—CA4—Metabolism—INS—type 2 diabetes mellitus	1.43e-05	0.000345	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARA—type 2 diabetes mellitus	1.43e-05	0.000344	CbGpPWpGaD
Metolazone—CA9—Metabolism—AGT—type 2 diabetes mellitus	1.38e-05	0.000333	CbGpPWpGaD
Metolazone—CA9—Metabolism—CALM1—type 2 diabetes mellitus	1.36e-05	0.000328	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOE—type 2 diabetes mellitus	1.36e-05	0.000326	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA1—type 2 diabetes mellitus	1.34e-05	0.000323	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—type 2 diabetes mellitus	1.31e-05	0.000316	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-05	0.000303	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-05	0.000303	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARG—type 2 diabetes mellitus	1.18e-05	0.000284	CbGpPWpGaD
Metolazone—CA9—Metabolism—INS—type 2 diabetes mellitus	1.16e-05	0.000279	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	1.15e-05	0.000277	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—type 2 diabetes mellitus	1.06e-05	0.000256	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—type 2 diabetes mellitus	1.02e-05	0.000245	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.02e-05	0.000245	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	9.29e-06	0.000224	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	8.38e-06	0.000202	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	7.82e-06	0.000188	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—type 2 diabetes mellitus	7.82e-06	0.000188	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—type 2 diabetes mellitus	7.25e-06	0.000174	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—type 2 diabetes mellitus	5.78e-06	0.000139	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—type 2 diabetes mellitus	4.67e-06	0.000112	CbGpPWpGaD
